Adaptimmune Ther ADR (ADAP)
0.2699 x 37 0.2755 x 13
Post-market by (Cboe BZX)
0.2771 +0.0071 (+2.63%) 04/28/25 [NASDAQ]
0.2699 x 37 0.2755 x 13
Post-market 0.2755 -0.0016 (-0.58%) 16:01 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ADAP | VTYX | GNTA | ||
| Company | Adaptimmune Ther ADR | Ventyx Biosciences Inc | Genenta Science S.P.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.2700 | 1.2000 | 4.10 | ||
| High | 0.2875 | 1.2500 | 4.15 | ||
| Low | 0.2661 | 1.1800 | 4.08 | ||
| Last | 0.2771 | 1.2400 | 4.08 | ||
| Change | +0.0118 | +0.0400 | +0.04 | ||
| % Change | +4.45% | +3.33% | +0.99% | ||
| Volume | 411,606 | 656,216 | 2,624 | ||
| 20-Day Average Volume | 1,822,525 | 1,329,351 | 7,806 | ||
| Previous Close | 0.2653 | 1.2000 | 4.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2511 | 1.0689 | 3.82 | ||
| 20-Day Raw Stochastic | 60.74% | 91.95% | 84.09% | ||
| 20-Day Relative Strength | 42.96% | 49.54% | 54.81% | ||
| Weighted Alpha | -69.99 | -67.92 | -7.33 | ||
| Today's Opinion | 88% Sell | 88% Sell | 64% Sell | ||
| Previous Opinion | 88% Sell | 88% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.41% since 04/21/25 | +9.73% since 04/21/25 | +5.43% since 04/21/25 | ||
| Low | 0.2401 on 04/22/25 | 1.1400 on 04/23/25 | 3.60 on 04/23/25 | ||
| High | 0.2977 on 04/23/25 | 1.2800 on 04/25/25 | 4.22 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +34.51% since 03/28/25 | +2.48% since 03/28/25 | +2.77% since 03/28/25 | ||
| Low | 0.1951 on 04/01/25 | 0.7830 on 04/07/25 | 3.34 on 04/07/25 | ||
| High | 0.3301 on 04/03/25 | 1.2800 on 04/25/25 | 4.22 on 04/24/25 | ||
| 3-Month | |||||
| %Chg | -53.03% since 01/28/25 | -38.61% since 01/28/25 | -0.24% since 01/28/25 | ||
| Low | 0.1951 on 04/01/25 | 0.7830 on 04/07/25 | 3.34 on 04/07/25 | ||
| High | 0.6214 on 02/10/25 | 2.1450 on 01/31/25 | 4.83 on 03/05/25 | ||
| 6-Month | |||||
| %Chg | -62.41% since 10/28/24 | -46.32% since 10/28/24 | -24.44% since 10/28/24 | ||
| Low | 0.1951 on 04/01/25 | 0.7830 on 04/07/25 | 3.34 on 04/07/25 | ||
| High | 0.8600 on 11/06/24 | 3.3900 on 12/06/24 | 5.89 on 11/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 66,392 | 66,848 | 66,027 | ||
| Shares Outstanding, K | 257,232 | 71,130 | 18,290 | ||
| Annual Sales | 178,030,000 | 0 | 0 | ||
| Annual Net Income | -70,810,000 | -135,120,000 | -9,640,000 | ||
| Last Quarter Sales | 3,220,000 | 0 | N/A | ||
| Last Quarter Net Income | -74,220,000 | -29,350,000 | N/A | ||
| 60-Month Beta | 2.84 | 0.75 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 03/24/25 | -0.41 on 02/27/25 | N/A | ||
| Latest Earnings Date | 05/21/25 | 05/08/25 | 04/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||